Cargando…

Heterologous Immunity between Adenoviruses and Hepatitis C Virus: A New Paradigm in HCV Immunity and Vaccines

Adenoviruses (Ad) are commonly used as vectors for gene therapy and/or vaccine delivery. Recombinant Ad vectors are being tested as vaccines for many pathogens. We have made a surprising observation that peptides derived from various hepatitis C virus (HCV) antigens contain extensive regions of homo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Shakti, Vedi, Satish, Samrat, Subodh Kumar, Li, Wen, Kumar, Rakesh, Agrawal, Babita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709057/ https://www.ncbi.nlm.nih.gov/pubmed/26751211 http://dx.doi.org/10.1371/journal.pone.0146404

Ejemplares similares

Heterologous Immunity between Adenoviruses and Hepatitis C Virus (HCV): Recombinant Adenovirus Vaccine Vectors Containing Antigens from Unrelated Pathogens Induce Cross-Reactive Immunity Against HCV Antigens
por: Agrawal, Babita, et al.
Publicado: (2019)

Unsolved Puzzles Surrounding HCV Immunity: Heterologous Immunity Adds Another Dimension
por: Agrawal, Babita, et al.
Publicado: (2017)

Alternate Reading Frame Protein (F Protein) of Hepatitis C Virus: Paradoxical Effects of Activation and Apoptosis on Human Dendritic Cells Lead to Stimulation of T Cells
por: Samrat, Subodh Kumar, et al.
Publicado: (2014)

Editorial: Heterologous Immunity: Implications and Applications in Vaccines and Immunotherapies
por: Singh, Shakti, et al.
Publicado: (2020)

Heterologous Immunity: Role in Natural and Vaccine-Induced Resistance to Infections
por: Agrawal, Babita
Publicado: (2019)

Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine
por: Gupta, Nancy, et al.
Publicado: (2018)

Harnessing Innate Immunity to Treat Mycobacterium tuberculosis Infections: Heat-Killed Caulobacter crescentus as a Novel Biotherapeutic
por: Gupta, Nancy, et al.
Publicado: (2023)

Heterologous immunity induced by 1(st) generation COVID-19 vaccines and its role in developing a pan-coronavirus vaccine
por: Patel, Raj S., et al.
Publicado: (2022)

Broader use of hepatitis B virus vaccine: Efficacy in those who lost hepatitis B surface antigen during follow-up
por: Kumar, Rakesh, et al.
Publicado: (2011)

New Players in Immunity to Tuberculosis: The Host Microbiome, Lung Epithelium, and Innate Immune Cells
por: Gupta, Nancy, et al.
Publicado: (2018)

Effect of route of delivery on heterologous protection against HCV induced by an adenovirus vector carrying HCV structural genes
por: Guan, Jie, et al.
Publicado: (2011)

Hepatitis C Virus (HCV)–Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design
por: Wrensch, Florian, et al.
Publicado: (2018)

Immune Recognition of Gene Transfer Vectors: Focus on Adenovirus as a Paradigm
por: Aldhamen, Yasser Ali, et al.
Publicado: (2011)

Heterologous T cell immunity in severe hepatitis C virus infection
por: Urbani, Simona, et al.
Publicado: (2005)

Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults
por: Coughlan, L., et al.
Publicado: (2018)

Heterologous immunization with adenovirus vectored and inactivated vaccines effectively protects against SARS-CoV-2 variants in mice and macaques
por: He, Qian, et al.
Publicado: (2022)

Virus-Induced T Cell-Mediated Heterologous Immunity and Vaccine Development
por: Balz, Kathrin, et al.
Publicado: (2020)

Pathogenic epitopes, heterologous immunity and vaccine design
por: Welsh, Raymond M., et al.
Publicado: (2007)

Enhanced immune response against HIV-1 induced by a heterologous DNA prime-adenovirus boost vaccination using mannosylated polyethyleneimine as DNA vaccine adjuvant
por: Li, Man, et al.
Publicado: (2013)

Sexual Transmission of HCV in Heterologous Monogamous Spouses
por: Rafik, Mona M., et al.
Publicado: (2014)

Aggravation of hyperthyroidism after heterologous prime-boost immunization with inactivated and adenovirus-vectored SARS-CoV-2 vaccine in a patient with Graves’ disease
por: Sriphrapradang, Chutintorn
Publicado: (2021)

Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen
por: Alekseeva, Ekaterina, et al.
Publicado: (2009)

Heterologous effects of infant BCG vaccination: potential mechanisms of immunity
por: Butkeviciute, Egle, et al.
Publicado: (2018)

Heterologous vaccine interventions: boosting immunity against future pandemics
por: Marín-Hernández, Daniela, et al.
Publicado: (2021)

Private aspects of heterologous immunity
por: Rehermann, Barbara, et al.
Publicado: (2005)

Trends of humoral immune responses to heterologous antigenic exposure due to vaccination & omicron SARS-CoV-2 infection: Implications for boosting
por: Batra, Gaurav, et al.
Publicado: (2023)

Editorial: Influenza Virus Vaccines and Immunotherapies
por: Kumar, Arun, et al.
Publicado: (2015)

Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
por: Liu, J, et al.
Publicado: (2012)

Adenovirus-prime and baculovirus-boost heterologous immunization achieves sterile protection against malaria sporozoite challenge in a murine model
por: Yoshida, Kunitaka, et al.
Publicado: (2018)

Heterologous chimpanzee adenovirus vector immunizations for SARS-CoV-2 spike and nucleocapsid protect hamsters against COVID-19
por: Hasanpourghadi, Mohadeseh, et al.
Publicado: (2023)

The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development
por: Cashman, Siobhán B., et al.
Publicado: (2014)

To Include or Occlude: Rational Engineering of HCV Vaccines for Humoral Immunity
por: Schlotthauer, Felicia, et al.
Publicado: (2021)

Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine
por: Nguyen, Thuy Trang, et al.
Publicado: (2022)

Cross-Reactive Effects of Vaccines: Heterologous Immunity between Tetanus and Chlamydia
por: Stojanovic, Marijana, et al.
Publicado: (2020)

Heterologous COVID-19 vaccination as a strategy to accelerate mass immunization
por: Klastrup, Vibeke, et al.
Publicado: (2022)

New therapeutic targets for cancer: the interplay between immune and metabolic checkpoints and gut microbiota
por: Agrawal, Babita
Publicado: (2019)

Biology of fowl adenovirus type 1 infection of heterologous cells
por: Taharaguchi, Satoshi, et al.
Publicado: (2012)

Impact of Preexisting Adenovirus Vector Immunity on Immunogenicity and Protection Conferred with an Adenovirus-Based H5N1 Influenza Vaccine
por: Pandey, Aseem, et al.
Publicado: (2012)

Evaluation of heterologous prime-boost vaccination strategies using chimpanzee adenovirus and modified vaccinia virus for TB subunit vaccination in rhesus macaques
por: Vierboom, Michel P. M., et al.
Publicado: (2020)

Adenovirus-Specific Immunity Following Immunization with an Ad5 HIV-1 Vaccine Candidate in Humans
por: O’Brien, Kara L., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_rtfv9f4srk72gpkunhn32ckn2u